Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients with heart failure (TARGET-HF): rationale and design of the single-arm intervention trial.
- DOI
- 10.1186/s40842-025-00260-6
- Published
- 2025 Dec 19
- Container
- Cardiovascular diabetology. Endocrinology reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40842-025-00260-6,
title = {Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients with heart failure (TARGET-HF): rationale and design of the single-arm intervention trial.},
author = {Okumura T and Bando YK and Isobe S and Fujita N and Sera F and Ikeda Y and Yajima A and Nagai T and Hiraiwa H and Morimoto R and Anzai T and Node K and Ako J and Sakata Y and Murohara T},
year = {2025},
journal = {Cardiovascular diabetology. Endocrinology reports},
doi = {10.1186/s40842-025-00260-6},
url = {https://doi.org/10.1186/s40842-025-00260-6}
}RIS
TY - JOUR TI - Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients with heart failure (TARGET-HF): rationale and design of the single-arm intervention trial. AU - Okumura T AU - Bando YK AU - Isobe S AU - Fujita N AU - Sera F AU - Ikeda Y AU - Yajima A AU - Nagai T AU - Hiraiwa H AU - Morimoto R AU - Anzai T AU - Node K AU - Ako J AU - Sakata Y AU - Murohara T PY - 2025 JO - Cardiovascular diabetology. Endocrinology reports DO - 10.1186/s40842-025-00260-6 UR - https://doi.org/10.1186/s40842-025-00260-6 ER -
APA
T, O., YK, B., S, I., N, F., F, S., Y, I., A, Y., T, N., H, H., R, M., T, A., K, N., J, A., Y, S., & T, M. (2025). Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients with heart failure (TARGET-HF): rationale and design of the single-arm intervention trial.. Cardiovascular diabetology. Endocrinology reports. https://doi.org/10.1186/s40842-025-00260-6
Source records
- pubmed · retrieved 2026-09-26T17:17:18.707Z